Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Noninvasive proteomic biomarkers for alcohol-related liver disease. | Nat Med | 2022 | 35654907 | PubTator, text mining | PubMed |
| Safety, efficacy, and patient selection of ripasudil in patients with uncontrolled glaucoma with maximum conventional medical therapy. | Indian J Ophthalmol | 2022 | 35647972 | PubTator, text mining | PubMed |
| Newer advances in medical management of glaucoma. | Indian J Ophthalmol | 2022 | 35647957 | PubTator, text mining | PubMed |
| Toward Precision Medicine with Human Pluripotent Stem Cells for Diabetes. | Stem Cells Transl Med | 2022 | 35640144 | PubTator, text mining | PubMed |
| Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases. | J Pers Med | 2022 | 35629192 | PubTator, text mining | PubMed |
| Systematic Review and Meta-Analysis on MS-Based Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Bipolar Disorder. | Int J Mol Sci | 2022 | 35628270 | PubTator, text mining | PubMed |
| Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. | Cancers (Basel) | 2022 | 35626089 | PubTator, text mining | PubMed |
| MicroRNA-503 Exacerbates Myocardial Ischemia/Reperfusion Injury via Inhibiting PI3K/Akt- and STAT3-Dependent Prosurvival Signaling Pathways. | Oxid Med Cell Longev | 2022 | 35620576 | PubTator, text mining | PubMed |
| Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease. | Blood Adv | 2022 | 35617682 | PubTator, text mining | PubMed |
| Molecular mechanisms underlying the heterogeneous barrier responses of two primary endothelial cell types to sphingosine-1-phosphate. | Eur J Cell Biol | 2022 | 35605366 | PubTator, text mining | PubMed |
| The V2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells. | J Endocrinol Invest | 2022 | 35604542 | PubTator, text mining | PubMed |
| Antidepressants induce toxicity in human placental BeWo cells. | Curr Res Toxicol | 2022 | 35602006 | PubTator, text mining | PubMed |
| Simvastatin alleviates epithelial-mesenchymal transition and oxidative stress of high glucose-induced lens epithelial cells in vitro by inhibiting RhoA/ROCK signaling. | Exp Ther Med | 2022 | 35601076 | PubTator, text mining | PubMed |
| RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality? | Front Oncol | 2022 | 35600358 | PubTator, text mining | PubMed |
| MARK2 regulates directed cell migration through modulation of myosin II contractility and focal adhesion organization. | Curr Biol | 2022 | 35594862 | PubTator, text mining | PubMed |
| M2 macrophage facilitated angiogenesis in cutaneous squamous cell carcinoma via circ_TNFRSF21/miR-3619-5p/ROCK axis. | Kaohsiung J Med Sci | 2022 | 35593591 | PubTator, text mining | PubMed |
| LncRNAs and CircRNAs in cancer. | MedComm (2020) | 2022 | 35592755 | PubTator, text mining | PubMed |
| Greek Fire, Poison Arrows, and Scorpion Bombs: How Tumor Cells Defend Against the Siege Weapons of Cytotoxic T Lymphocytes. | Front Immunol | 2022 | 35592329 | PubTator, text mining | PubMed |
| The heparan sulphate proteoglycan Syndecan-1 (CD138) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breast. | IUBMB Life | 2022 | 35587107 | PubTator, text mining | PubMed |
| Profilin 1 Induces Tumor Metastasis by Promoting Microvesicle Secretion Through the ROCK 1/p-MLC Pathway in Non-Small Cell Lung Cancer. | Front Pharmacol | 2022 | 35586060 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=44